# US 10,767,222 B2 · Compositions and methods for detecting rare sequence variants

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 10,767,222 B2
- Document ID: US10767222B2
- Status: Granted
- Kind: B2
- Application number: 15/102,241
- Filed: 2014-12-11
- Published: 2016-10-20
- Granted: 2020-09-08
- Earliest claimed: 2013-12-11
- Assignees: Accuragen Holdings Limited
- Applicants: Accuragen Holdings Limited
- Inventors: Shengrong Lin; Zhaohui Sun; Grace Qizhi Zhao; Paul Ling-Fung Tang
- Web page: https://patentgrep.com/patent/US10767222B2

## CPC

- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/6869: Methods for sequencing
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

In some aspects, the present disclosure provides methods for identifying sequence variants in a nucleic acid sample. In some embodiments, a method comprises identifying sequence differences between sequencing reads and a reference sequence, and calling a sequence difference that occurs in at least two different circular polynucleotides, such as two circular polynucleotides having different junctions, as the sequence variant. In some aspects, the present disclosure provides compositions and systems useful in the described methods.

## Claims

### Claim 1

A method of distinguishing a sequence variant from an error in a nucleic acid sample comprising a plurality of cell-free polynucleotides, each cell-free polynucleotide of the plurality having a 5′ end and a 3′ end, the method comprising:
(a) circularizing individual cell-free polynucleotides of said plurality to form a plurality of circular polynucleotides, each of which having a junction between the 5′ end and 3′ end;
(b) amplifying the circular polynucleotides of (a);
(c) sequencing the amplified polynucleotides to produce a plurality of sequencing reads; and
(d) identifying a sequence difference between sequencing reads and a reference sequence as the sequence variant only when the sequence difference occurs in at least two circular polynucleotides having different junctions and not when the sequence difference only occurs in circular polynucleotides having the same junction thereby distinguishing the sequence variant from the error.

### Claim 2 (depends on 1)

The method of claim 1, wherein the plurality of cell-free polynucleotides are single-stranded.

### Claim 3 (depends on 1)

The method of claim 1, wherein circularizing is effected by subjecting the plurality of cell-free polynucleotides to a ligation reaction comprising a ligase.

### Claim 4 (depends on 3)

The method of claim 3, wherein ligation is effected by a ligase, and the method further comprises degrading the ligase prior to the amplifying of step (b).

### Claim 5 (depends on 1)

The method of claim 1, wherein the sequence variant is a single nucleotide polymorphism.

### Claim 6 (depends on 1)

The method of claim 1, wherein the reference sequence is a consensus sequence formed by aligning the sequencing reads with one another or the reference sequence is a known reference sequence.

### Claim 7 (depends on 1)

The method of claim 1, wherein the individual cell-free polynucleotides circularized in (a) are RNA, and amplifying the circular RNA in (b) involves a primer extension reaction selected from the group consisting of: reverse transcription, polymerase chain reaction, isothermal amplification, and combinations thereof.

### Claim 8 (depends on 1)

The method of claim 1, wherein circularizing comprises the step of joining an adapter polynucleotide to the 5′ end, the 3′ end, or both the 5′ end and the 3′ end of a cell-free polynucleotide in the plurality of cell-free polynucleotides.

### Claim 9 (depends on 1)

The method of claim 1, wherein amplifying is effected by using a polymerase having strand-displacement activity.

### Claim 10 (depends on 1)

The method of claim 1, wherein amplifying comprises subjecting the circular polynucleotides to an amplification reaction mixture comprising random primers.

### Claim 11 (depends on 1)

The method of claim 1, wherein amplifying comprises subjecting the circular polynucleotides to an amplification reaction mixture comprising one or more primers, each of which specifically hybridizes to a different target sequence via sequence complementarity.

### Claim 12 (depends on 1)

The method of claim 1, wherein the amplified polynucleotides are subjected to the sequencing step without enrichment.

### Claim 13 (depends on 1)

The method of claim 1, further comprising performing an enrichment step on the amplified polynucleotides to enrich one or more target polynucleotides.

### Claim 14 (depends on 13)

The method of claim 13, wherein the enrichment step comprises amplifying a target sequence comprising sequence A and sequence B oriented in a 5′ to 3′ direction in an amplification reaction mixture, said reaction mixture comprising:
(a) the amplified polynucleotides;
(b) a first primer comprising sequence A′, wherein the first primer specifically hybridizes to sequence A of the target sequence via sequence complementarity between sequence A and sequence A′;
(c) a second primer comprising sequence B, wherein the second primer specifically hybridizes to sequence B′ present in a complementary polynucleotide comprising a complement of the target sequence via sequence complementarity between B and B′; and
(d) a polymerase that extends the first primer and the second primer to produce amplified polynucleotides;
wherein the distance between the 5′ end of sequence A and the 3′ end of sequence B of the target sequence is 75nt or less; and
wherein sequence A and sequence B′ are present in the nucleic acid sample.

### Claim 15 (depends on 1)

The method of claim 1, wherein the cell-free polynucleotides comprise cell-free tumor DNA or RNA.

### Claim 16 (depends on 1)

The method of claim 1, wherein identifying a sequence difference is performed by a computer system based on the sequencing reads and the reference sequence.

### Claim 17

A method of distinguishing a sequence variant from an error in a nucleic acid sample comprising less than 75 ng of cell-free polynucleotides, each polynucleotide having a 5′ end and a 3′ end, the method comprising:
(a) obtaining a nucleic acid sample comprising less than 75 ng of cell-free polynucleotides;
(b) circularizing with a ligase individual cell-free polynucleotides in said sample to form a plurality of circular polynucleotides;
(c) upon separating said ligase from said circular polynucleotides, amplifying the circular polynucleotides to form concatemers;
(d) sequencing the concatemers to produce a plurality of sequencing reads; and
(e) identifying a sequence difference between the plurality of sequencing reads and a reference sequence as a sequence variant that occurs with a frequency of 1% or lower in said plurality of reads from said nucleic acid sample of less than 75 ng polynucleotides as the sequence variant only when the sequence difference occurs in at least two circular polynucleotides having different junctions and not when the sequence difference only occurs in circular polynucleotides having the same junction thereby distinguishing the sequence variant from the error.

### Claim 18 (depends on 17)

The method of claim 17, wherein the polynucleotides of the sample are single-stranded.

### Claim 19 (depends on 17)

The method of claim 17, wherein the reference sequence is a consensus sequence formed by aligning the sequencing reads with one another.

### Claim 20 (depends on 17)

The method of claim 17, wherein the reference sequence is a known reference sequence.

### Claim 21 (depends on 17)

The method of claim 17, wherein amplifying is effected by using a polymerase having strand-displacement activity.

### Claim 22 (depends on 17)

The method of claim 17, wherein amplifying comprises subjecting the circular polynucleotides to an amplification reaction mixture comprising random primers.

### Claim 23 (depends on 17)

The method of claim 17, wherein amplifying comprises subjecting the circular polynucleotides to an amplification reaction mixture comprising one or more primers, each of which specifically hybridizes to a different target sequence via sequence complementarity.

### Claim 24 (depends on 17)

The method of claim 17, wherein the polynucleotides of the sample comprise cell-free tumor DNA or RNA.

### Claim 25 (depends on 17)

The method of claim 17, wherein separating said ligase comprises degrading the ligase.

### Claim 26 (depends on 17)

The method of claim 17, wherein the nucleic acid sample comprising less than 75 ng of polynucleotides is from a sample of a subject.